Vaccine News and Research

Latest Vaccine News and Research

Anti-heroin vaccine developed at TSRI proven effective in primate models

A vaccine developed at The Scripps Research Institute (TSRI) to block the "high" of heroin has proven effective in non-human primates. This is the first vaccine against an opioid to pass this stage of preclinical testing.

6 Jun 2017

Obese people twice as likely to develop influenza despite getting flu shots

Although influenza vaccines are currently the best forms of protection to safeguard people against getting the flu, they are not effective in all cases.

6 Jun 2017

Scientists discover mechanism that provides potential new target for allergy treatments

In news that may bring hope to asthma sufferers, scientists discover a mechanism that provides a possible new target for allergy treatments.

6 Jun 2017

Research shows new Zika virus vaccine that offers 100% protection in mice

Research presented by Farshad Guirakhoo, Ph.D., Chief Scientific Officer, GeoVax, Inc., at the ASM Microbe 2017 meeting showed a new Zika virus vaccine that gives 100% protection in mice.

5 Jun 2017

Early study of experimental vaccine shows escalating immune response in patients with sarcoma

The critical component of an experimental vaccine led to an escalating immune response in patients with sarcoma, an indicator of its potential anti-cancer effects.

2 Jun 2017

TSRI study reveals first-ever structure of Lassa virus protein

Before Ebola virus ever struck West Africa, locals were already on the lookout for a deadly pathogen: Lassa virus. With thousands dying from Lassa every year - and the potential for the virus to cause even larger outbreaks- researchers are committed to designing a vaccine to stop it.

1 Jun 2017

Experimental drug increases progression-free survival in pancreatic cancer patients, clinical trial shows

By adding an experimental drug to a standard chemotherapy regimen, a subset of patients with metastatic pancreatic cancer had a significantly longer period before the cancer progressed as compared with those who received the standard treatment, according to a Phase 2 clinical trial led by an investigator at Fred Hutchinson Cancer Research Center.

1 Jun 2017

Study finds decline in rates of HPV-related precancerous cervical lesions among women in Connecticut

The vaccine for the Human Papillomavirus is proving to have significant population-level effects in Connecticut, with rates of precancerous lesions caused by HPV down drastically among young women, a new Yale School of Public Health study finds.

31 May 2017

MGH scientists show how Shigella survives journey from mouth to the colon

Surviving the treacherous journey through the human body from the mouth to the colon takes a special kind of bacterial pathogen.

31 May 2017

Novel vaccine therapy can generate immune responses in patients with HPV-related head and neck cancer

A novel vaccine therapy can generate immune responses in patients with head and neck squamous cell carcinoma (HNSCCa), according to researchers at the Abramson Cancer Center of the University of Pennsylvania.

31 May 2017

Combining oral drug with personalized cell therapy can lead to complete remission in CLL patients

Combining the kinase inhibitor ibrutinib with an investigational personalized cellular therapy known as CTL119 can lead to complete remission in patients with high-risk chronic lymphocytic leukemia (CLL), according to new research from the Perelman School of Medicine at the University of Pennsylvania and Penn's Abramson Cancer Center

31 May 2017

Many cancer patients' ED visits could be avoided with better symptom management, timely care

As many as 53 percent of cancer patients' Emergency Department visits that do not require admission could be avoided with better symptom management and greater availability of outpatient care tailored to their needs, according to a new study from Fred Hutchinson Cancer Research Center.

31 May 2017

Scientists could be one step closer to developing vaccines against viruses

Scientists could be one step closer to developing vaccines against viruses such as Zika, West Nile or HIV, according to Penn State College of Medicine researchers.

31 May 2017

Radboudumc, iMM Lisboa, PATH team up to test new malaria vaccine concept

The Radboud University Medical Center in the Netherlands, the Instituto de Medicina Molecular Lisboa in Portugal, and PATH in Seattle, Washington announced today that they will collaborate to test a new approach to malaria vaccine development in humans for the first time.

31 May 2017

Small clinical trial reveals promising results of triple immunotherapy in treating rare skin cancer

Three out of four patients treated with an experimental combination of three different therapies for the rare skin cancer known as Merkel cell carcinoma are in complete remission following the treatment, according to study results from a small clinical trial led at Fred Hutchinson Cancer Research Center.

31 May 2017

Zika entry into India – cause for concern

The Zika virus has finally wormed its way into one of the largest and most densely populated countries in the world, India. The World Health Organization reported that surveillance efforts should be strengthened here in order to curb the menace and prevent its spread.

30 May 2017

A new Zika threat hovers as summer’s mosquitoes get bzzzzy

Zika, the mosquito-borne virus that triggered public health alarm bells last summer, has receded from the spotlight. But, experts say, expect the virus to pose a renewed threat this year.

30 May 2017

Scripps scientists make important advance in HIV vaccine design

Scientists at The Scripps Research Institute (TSRI) have made another important advance in HIV vaccine design. The development was possible thanks to previous studies at TSRI showing the structures of a protein on HIV’s surface, called the envelope glycoprotein. The scientists used these structures to design a mimic of the viral protein from a different HIV subtype, subtype C, which is responsible for the majority of infections worldwide.

29 May 2017

Researchers develop new method for rapidly sorting HIV viruses

Researchers at EMBL, ESPCI Paris, and the International AIDS Vaccine Initiative have developed a new technique for rapidly sorting HIV viruses, which could lead to more rapid development of a vaccine for HIV, as they report in Cell Chemical Biology.

25 May 2017

Study: Early-stage breast cancer patients undergo inappropriate tests that may increase financial burden

A study from Fred Hutchinson Cancer Research Center that will be presented at the American Society of Clinical Oncology annual meeting on June 5 in Chicago shows that asymptomatic women who have been treated for early-stage breast cancer often undergo advanced imaging and other tests that provide little if any medical benefit, could have harmful effects and may increase their financial burden.

25 May 2017

Vaccine News and Research

Latest Vaccine News and Research

Anti-heroin vaccine developed at TSRI proven effective in primate models

Obese people twice as likely to develop influenza despite getting flu shots

Scientists discover mechanism that provides potential new target for allergy treatments

Research shows new Zika virus vaccine that offers 100% protection in mice

Early study of experimental vaccine shows escalating immune response in patients with sarcoma

TSRI study reveals first-ever structure of Lassa virus protein

Experimental drug increases progression-free survival in pancreatic cancer patients, clinical trial shows

Study finds decline in rates of HPV-related precancerous cervical lesions among women in Connecticut

MGH scientists show how Shigella survives journey from mouth to the colon

Novel vaccine therapy can generate immune responses in patients with HPV-related head and neck cancer

Combining oral drug with personalized cell therapy can lead to complete remission in CLL patients

Many cancer patients' ED visits could be avoided with better symptom management, timely care

Scientists could be one step closer to developing vaccines against viruses

Radboudumc, iMM Lisboa, PATH team up to test new malaria vaccine concept

Small clinical trial reveals promising results of triple immunotherapy in treating rare skin cancer

Zika entry into India – cause for concern

A new Zika threat hovers as summer’s mosquitoes get bzzzzy

Scripps scientists make important advance in HIV vaccine design

Researchers develop new method for rapidly sorting HIV viruses

Study: Early-stage breast cancer patients undergo inappropriate tests that may increase financial burden

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Newsletters you may be interested in